These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 23936343)
1. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice. Lee D; Lee KH; Park H; Kim SH; Jin T; Cho S; Chung JH; Lim S; Park S PLoS One; 2013; 8(8):e69669. PubMed ID: 23936343 [TBL] [Abstract][Full Text] [Related]
2. Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE. Jeong J; Lee J; Lim J; Cho S; An S; Lee M; Yoon N; Seo M; Lim S; Park S Exp Mol Med; 2019 Sep; 51(9):1-15. PubMed ID: 31562296 [TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 analogue liraglutide ameliorates atherogenesis via inhibiting advanced glycation end product-induced receptor for advanced glycosylation end product expression in apolipoprotein-E deficient mice. Li P; Tang Z; Wang L; Feng B Mol Med Rep; 2017 Sep; 16(3):3421-3426. PubMed ID: 28713911 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis. Ha CH; Kim S; Chung J; An SH; Park S; Choi D; Kwon K Int J Mol Med; 2013 Aug; 32(2):373-80. PubMed ID: 23708564 [TBL] [Abstract][Full Text] [Related]
5. Soluble RAGE attenuates Ang II-induced arterial calcification via inhibiting AT1R-HMGB1-RAGE axis. Jeong J; Cho S; Seo M; Lee BS; Jang Y; Lim S; Park S Atherosclerosis; 2022 Apr; 346():53-62. PubMed ID: 35278873 [TBL] [Abstract][Full Text] [Related]
6. Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice. Dou L; Lu Y; Shen T; Huang X; Man Y; Wang S; Li J Cell Physiol Biochem; 2012; 29(5-6):875-82. PubMed ID: 22613987 [TBL] [Abstract][Full Text] [Related]
7. Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis. Liu M; Yu Y; Jiang H; Zhang L; Zhang PP; Yu P; Jia JG; Chen RZ; Zou YZ; Ge JB Acta Pharmacol Sin; 2013 Jun; 34(6):830-6. PubMed ID: 23564080 [TBL] [Abstract][Full Text] [Related]
8. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice. Bu DX; Rai V; Shen X; Rosario R; Lu Y; D'Agati V; Yan SF; Friedman RA; Nuglozeh E; Schmidt AM Circ Res; 2010 Apr; 106(6):1040-51. PubMed ID: 20133903 [TBL] [Abstract][Full Text] [Related]
9. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis. Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587 [TBL] [Abstract][Full Text] [Related]
10. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Bucciarelli LG; Wendt T; Qu W; Lu Y; Lalla E; Rong LL; Goova MT; Moser B; Kislinger T; Lee DC; Kashyap Y; Stern DM; Schmidt AM Circulation; 2002 Nov; 106(22):2827-35. PubMed ID: 12451010 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis. Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193 [TBL] [Abstract][Full Text] [Related]
12. Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice. Watson AM; Li J; Samijono D; Bierhaus A; Thomas MC; Jandeleit-Dahm KA; Cooper ME Atherosclerosis; 2014 Aug; 235(2):444-8. PubMed ID: 24945577 [TBL] [Abstract][Full Text] [Related]
13. Polychlorinated biphenyl 77 augments angiotensin II-induced atherosclerosis and abdominal aortic aneurysms in male apolipoprotein E deficient mice. Arsenescu V; Arsenescu R; Parulkar M; Karounos M; Zhang X; Baker N; Cassis LA Toxicol Appl Pharmacol; 2011 Nov; 257(1):148-54. PubMed ID: 21925196 [TBL] [Abstract][Full Text] [Related]
14. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes. Wendt T; Harja E; Bucciarelli L; Qu W; Lu Y; Rong LL; Jenkins DG; Stein G; Schmidt AM; Yan SF Atherosclerosis; 2006 Mar; 185(1):70-7. PubMed ID: 16076470 [TBL] [Abstract][Full Text] [Related]
15. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Morris-Rosenfeld S; Blessing E; Preusch MR; Albrecht C; Bierhaus A; Andrassy M; Nawroth PP; Rosenfeld ME; Katus HA; Bea F Eur J Clin Invest; 2011 Nov; 41(11):1164-71. PubMed ID: 21418204 [TBL] [Abstract][Full Text] [Related]
19. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738 [TBL] [Abstract][Full Text] [Related]
20. Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice. Tang T; Wilson PG; Thompson JC; Nelson C; Yoder MH; Tannock LR J Lipid Res; 2013 Aug; 54(8):2255-2264. PubMed ID: 23749984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]